141 related articles for article (PubMed ID: 11896536)
1. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
2. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
3. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
Nückel H; Frey UH; Röth A; Dührsen U; Siffert W
Eur J Pharmacol; 2005 May; 514(2-3):217-24. PubMed ID: 15910809
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
5. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
6. Comparative flow cytometric evaluation of bcl-2 oncoprotein in CD5+ and CD5- B-cell lymphoid chronic leukemias.
Molica S; Mannella A; Crispino G; Dattilo A; Levato D
Haematologica; 1997; 82(5):555-9. PubMed ID: 9407720
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
Bannerji R; Kitada S; Flinn IW; Pearson M; Young D; Reed JC; Byrd JC
J Clin Oncol; 2003 Apr; 21(8):1466-71. PubMed ID: 12697868
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
[TBL] [Abstract][Full Text] [Related]
10. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
11. Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
Renaudineau Y; Nédellec S; Berthou C; Lydyard PM; Youinou P; Pers JO
Leukemia; 2005 Feb; 19(2):223-9. PubMed ID: 15618965
[TBL] [Abstract][Full Text] [Related]
12. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
[TBL] [Abstract][Full Text] [Related]
13. Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells.
Stanglmaier M; Reis S; Hallek M
Ann Hematol; 2004 Oct; 83(10):634-45. PubMed ID: 15309525
[TBL] [Abstract][Full Text] [Related]
14. [Apoptosis in chronic lymphocytic leukemia].
Giordano M
Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
[TBL] [Abstract][Full Text] [Related]
18. Combination of two anti-CD5 monoclonal antibodies synergistically induces complement-dependent cytotoxicity of chronic lymphocytic leukaemia cells.
Klitgaard JL; Koefoed K; Geisler C; Gadeberg OV; Frank DA; Petersen J; Jurlander J; Pedersen MW
Br J Haematol; 2013 Oct; 163(2):182-93. PubMed ID: 23927424
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias.
Cro L; Guffanti A; Colombi M; Cesana B; Grimoldi MG; Patriarca C; Goldaniga M; Neri A; Intini D; Cortelezzi A; Maiolo AT; Baldini L
Leukemia; 2003 Jan; 17(1):125-32. PubMed ID: 12529669
[TBL] [Abstract][Full Text] [Related]
20. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
